Fennec Pharmaceuticals (FENC) Cash from Operations (2010 - 2025)
Fennec Pharmaceuticals (FENC) posted Cash from Operations of 5962000.0 for Q4 2025, down 499.33% on a QoQ basis from 1493000.0 in Q3 2025, and down 304.48% year-over-year from 2915722.63 in Q4 2024.
Fennec Pharmaceuticals (FENC) Cash from Operations (2010 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Cash from Operations history runs 16 years deep, the most recent figure standing at 5962000.0 for Q4 2025.
- Quarterly Cash from Operations fell 304.48% year-over-year to 5962000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 12473000.0 (down 146.23% YoY) and the FY2025 annual result came in at 12473000.0, down 146.23% from the prior year.
- Cash from Operations was 5962000.0 for Q4 2025 at Fennec Pharmaceuticals, down from 1493000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 39047000.0 in Q1 2024 and bottomed at 8387000.0 in Q2 2024.
- A 5-year average of 1745800.0 and a median of 3639500.0 in 2021 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2024 — Cash from Operations surged 800.14% — and 2025, when it slumped 304.48%.
- Fennec Pharmaceuticals' Cash from Operations stood at 3245000.0 in 2021, then tumbled by 109.61% to 6802000.0 in 2022, then advanced by 28.55% to 4860000.0 in 2023, then jumped by 69.67% to 1474000.0 in 2024, then slumped by 304.48% to 5962000.0 in 2025.
- Business Quant data shows FENC's Cash from Operations at 5962000.0 in Q4 2025, 1493000.0 in Q3 2025, and 3686000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 201.34 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -354.17 Mn |
| 10 | Fennec Pharmaceuticals | 292.91 Mn | 256.13 Mn | 12.01 Mn | -5.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.96 Mn |
| Dec 31, 2025 | -5.96 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | -3.69 Mn |
| Jun 30, 2025 | -3.69 Mn |
| Mar 31, 2025 | -4.32 Mn |
| Mar 31, 2025 | -4.32 Mn |
| Dec 31, 2024 | -1.47 Mn |
| Dec 31, 2024 | -1.47 Mn |
| Sep 30, 2024 | -2.21 Mn |
| Sep 30, 2024 | -2.21 Mn |
| Jun 30, 2024 | -8.39 Mn |
| Jun 30, 2024 | -8.39 Mn |
| Mar 31, 2024 | 39.05 Mn |
| Mar 31, 2024 | 39.05 Mn |
| Dec 31, 2023 | -4.86 Mn |
| Dec 31, 2023 | -4.86 Mn |
| Sep 30, 2023 | -2.76 Mn |
| Sep 30, 2023 | -2.76 Mn |